Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Endolysins active against Bacillus bacteria, pharmaceutical compositions, and methods relating thereto

Endolysins active against Bacillus bacteria, pharmaceutical compositions, and methods relating thereto

US Patent 11890330 · Granted Feb 6, 2024

Estimated economic value: $74,975,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Di-enzymatic chimeric endolysin2021
Endolysins active against Staphylococcus bacteria, pharmaceutical compositions, 2018
Collapsible tie rack2018
Phage-associated lytic enzymes for treatment of Bacillus anthracis and related c2013
Bacteriophage lysins for Bacillus anthracis2013
Nucleic acids and polypeptides of C1 bacteriophage and uses thereof2010
Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other b2009
Nucleic acids and polypeptides of C1 bacteriophage and uses thereof2009
Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and rel2009
Phage-associated lytic enzymes for treatment of Bacillus anthracis and related c2008
Polypeptide having amidolytic activity for a serpin2004
C1 bacteriophage lytic system2003